DEA Ditches High-Level Federal Health Meeting On Cannabis Research: Another Expression Of Distaste For Cannabis Rescheduling?
Tension between the White House and the DEA over rescheduling continues; some officials argue medicinal benefits of cannabis remain unproven.
